OOIR: Observatory of International Research

Papers

(The TQCC of Trends in Cardiovascular Medicine is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Editorial commentary: Simplifying diagnostics in wide complex tachycardia: Not so simple	216
Editorial commentary: Factors underlying improved mortality in patients with atrial fibrillation	125
Is it the atrial arrhythmia or the atrial myopathy? Yes! (It's both)	111
Editorial commentary: Air pollution: The most important environmental threat to the cardiovascular system	107
Editorial commentary: Role of inflammatory cytokines in genesis and treatment of atherosclerosis. Looking at foam cells through a different lens	95
Percutaneous suture-based patent foramen ovale closure: A state-of-the-art review	92
Physiologic guidance for percutaneous coronary intervention: State of the evidence	82
Gender and race-related disparities in the management of ventricular arrhythmias	77
Pulmonary artery denervation for pulmonary arterial hypertension	73
Editorial commentary: Unraveling intricacies of cardiovascular disease at the single-cell resolution	57
Assessing functional status of cardiac lymphatics: From macroscopic imaging to molecular profiling	56
Editorial Board	55
Editorial commentary: The evolution of prosthetic heart valves and related preventative antithrombotic therapy: Different paths with divergent progression	50
Editorial commentary: Polygenic risk and coronary artery calcium score: Joining forces in preventive cardiology	44
Cardiac implantable electronic device infection	44
Editorial commentary: The enigma of the left atrial septal pouch	42
Head-to-head comparison between left atrial appendage occlusion and non-vitamin K oral anticoagulants in non-valvular atrial fibrillation patients: A systematic review and meta-analysis study	38
Editorial commentary: CardioVerse: Buying the stairway to heaven	38
Editorial commentary: Heart failure incidence and etiologies at young adult age	38
Innovations in cardiovascular imaging	36
Unmet clinical needs in the prevention and treatment of cancer-associated venous thromboembolism	34
Editorial Board	33
Editorial commentary: Diagnosis of pulmonary embolism: Know your strengths well, and know your weaknesses better	33
Invasive management of unroofed coronary sinus: A systematic review	33
Editorial commentary: Respect or resect? Patient tailored approach	32

Role of platelet function and genetic testing in patients undergoing percutaneous coronary intervention	32
Non-invasive ablation of arrhythmias with stereotactic ablative radiotherapy	31
Radial artery or saphenous vein?	30
Epicardial Adipose Tissue and Heart Failure.	29
Editorial commentary: “Three steps to ACM diagnosis – is it that easy?”	29
Access routes, devices and guidance methods for intrapericardial delivery in cardiac conditions	28
Advances in the screening, diagnosis, and treatment of transthyretin amyloid cardiomyopathy: New insights and future directions	27
Regression and stabilization of atherogenic plaques	27
Coronary artery embolism and acute coronary syndrome: A critical appraisal of existing data	25
Thromboembolic risk and oral anticoagulation in subclinical atrial fibrillation	25
Editorial Board	22
Spotlight on ATTR cardiomyopathy: the unexpected journey of a once considered “orphan disease”	22
Editorial Board	22
Surgical vs transcatheter aortic valve replacement in bicuspid aortic valve stenosis: A systematic review and meta-analysis	22
Editorial commentary: Fibromuscular Dysplasia and Cervical Artery Dissection: Eyes do not see what the mind does not know	21
Editorial commentary: The heart at high altitude	20
Cardiovascular-liver-metabolic health: Time to integrate liver assessment into cardiology practice?	20
Effects of different exercise methods and intensities on the incidence and prognosis of atrial fibrillation	20
Atrial septal pouches and ridges: Morphological features and potential implications in clinical practice	20
Editorial commentary: COVID-19 as a cardiovascular disease risk factor	18
Editorial commentary: Exercise recommendations in hypertrophic cardiomyopathy shouldn't end at the recommendation	18
Editorial commentary: Highlighting important (selected) issues in hypertension therapeutics	17
Editorial commentary: Cardiac MRI imaging in heart failure with preserved ejection fraction	17
Understanding the pathogenesis of coronary slow flow: Recent advances	17
Response to the editorial commentary: “The relationship between alcohol intake and cardiovascular health: Gaps in knowledge”	17
Editorial commentary: Lyme carditis - “a ray of light revealed in a dark story” of dilated cardiomyopathy	17
Responses to the letter by Feka et al. regarding oral hydroquinidine as an alternative to intravenous quinidine	17
Robotic applications for intracardiac and endovascular procedures	17
Pulmonary hypertension in aortic valve stenosis	17
Unexplained sudden cardiac arrest and sudden cardiac death in the young: What is killing these young people when nothing is found?	16
Adverse effects of right ventricular pacing on cardiac function: prevalence, prevention and treatment with physiologic pacing	16
Update on the epidemiology, diagnosis, and management of infective endocarditis: A review	16
Atrial fibrillation in patients with cardiomyopathy – Protecting the vulnerable	15
Editorial commentary: Role of autonomic neuromodulation for the treatment of heart failure with reduced ejection fraction: The jury is still out	15
Editorial commentary: Non-invasive tools for risk stratification and treatment in Brugada syndrome: Less is more?	15
Isolated myocardial edema in cardiac magnetic resonance – in search of a management strategy	15
Editorial commentary: Applying guidelines directed medical therapy for heart failure: The cardiologist hard job	14
Editorial commentary: Trends in cardiovascular medicine From deep in the heart – An emerging role of cardiac lymphatics	14
ANGPTL3 inhibition, dyslipidemia, and cardiovascular diseases	14
Management of atrial fibrillation after transcatheter aortic valve replacement: Challenges and therapeutic considerations	14
Editorial Board	14
Editorial commentary: Robotic applications for intracardiac and endovascular procedures: Are we ready for robotic takeover?	14
Metabolic dysfunction-associated steatotic liver disease and the cardiovascular system	13
Primary aldosteronism	13
Editorial commentary: Uncomplicated type B aortic dissections - Optimizing a window of opportunity for endovascular intervention	12
Editorial Board	12
Editorial commentary: Atrial fibrillation in TAVR patients: A new therapeutic challenge	12
Editorial commentary: Cardiac allograft vasculopathy: Caveats and perspectives	12
The current state and future of renal denervation: A review	11
Editorial commentary: Myocardial edema: Bonum et laudabile	11

Editorial commentary: Left atrial appendage occlusion for prevention of thromboembolism in atrial fibrillation: Is it ready for first line therapy?	11
Depression pandemic and cardiovascular risk in the COVID-19 era and long COVID syndrome: Gender makes a difference	10
Transcatheter valvular interventions after heart transplantation: A systematic review	10
Editorial commentary: Emergence of nephrocardiology: Integrating management of cardiovascular and kidney diseases for holistic patient care	10
Editorial Commentary: Takotsubo syndrome: A key role for inflammation?	10
Consultation in the CardioVerse : The doctor will see your avatar now	9
Space for improvement: ZIP codes should not determine cardiovascular longevity, a scoping review	9
Concurrent percutaneous left atrial appendage occlusion and catheter ablation for atrial fibrillation: State-of-the-art review	9
Magnetic resonance imaging safety in patients with cardiac implantable electronic devices	9
The role of modern cardiovascular imaging in (suspected) coronary artery disease in competitive athletes	9
Editorial Board	9
Translational insights from single-cell technologies across the cardiovascular disease continuum	9
Artificial Intelligence and Transcatheter Interventions for Structural Heart Disease: A glance at the (near) future	9
Editorial commentary: FAME, ISCHEMIA and outcomes: Coronary physiology vs. plaque instability and myocardial infarction	9
Editorial commentary: Functional mitral regurgitation - a moving target in patients with heart failure	9
Editorial Board	9
Personalization of primary prevention: Exploring the role of coronary artery calcium and polygenic risk score in cardiovascular diseases	9
The right ventricle in “Left-sided” cardiomyopathies: The dark side of the moon	9
Heart failure with preserved ejection fraction assessed by cardiac magnetic resonance: From clinical uses to emerging techniques	8
Spontaneous coronary artery dissection: Overview of pathophysiology	8
Multimodality imaging for the global evaluation of aortic stenosis: The valve, the ventricle, the afterload	8
Use of direct oral anticoagulants in patients on chronic hemodialysis: Contemporary appraisal on the role for patients with atrial fibrillation	8
Zika & heart: A systematic review	8
Mechanical valve thrombosis: Current management and differences between guidelines	8
Removing the complexity from wide complex tachycardia	8
Editorial commentary: Who is at high-risk in J wave syndromes?	7
Editorial commentary: Heart failure home monitoring: Are we monitoring the patient or the disease?	7
Editorial commentary: Adiposity, altered inflammatory pathways, and atrial fibrillation: Mechanistic links or an epiphenomenon?	7
Editorial commentary: Screening for aortic stenosis in at risk older patients – A new paradigm in valvular heart disease care?	7
New Perspective on Pathophysiology and Management of Functional Mitral Regurgitation	7
Editorial Board	7
Editorial commentary: Adequate blood pressure control unattainable without adequate recognition and treatment of primary aldosteronism	7
Coronary computed tomography angiography in patients with stable coronary artery disease	7
Patient-centered care in geriatric cardiology	7
New trends in non-pharmacological approaches for cardiovascular disease: Therapeutic ultrasound	6
Editorial commentary: A new era for preventive cardiology	6
Evaluation of aortic stenosis: From Bernoulli and Doppler to Navier-Stokes	6
Editorial commentary: Infective endocarditis: Harnessing the power of advanced imaging	6
Editorial commentary: Enjoy the silence and darkness at sleep: new milestones on the road towards an exposomic approach to cardiovascular prevention	6
Circulating adipose tissue proteins involved in atrial fibrillation: An explorative scoping review	6
Enhanced cardiac PET: Illuminating the path to better CAD care—18F labeled myocardial perfusion PET	6
Stroke prevention in atrial fibrillation	6
Editorial commentary: To screen or not to screen - and other pending questions within the enigma of coronary artery anomalies	6
Editorial commentary: Influenza vaccine as part of a heart disease armamentarium in the new cardio-respiratory virus era	6
Editorial commentary: Extending the success of transcatheter valvular interventions to transplanted hearts	6